Clinical Trial Update: Niacin to Improve Blood Flow in People With Sickle Cell Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating niacin to improve血 flow in people with sickle cell disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Niacin (nicotinic acid)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Sickle Cell Disease | Phase 2 | Status: COMPLETED